9 results about "Stomach motility" patented technology

Provided in the present application are a composite Bifidobacterium preparation and the use thereof in yogurt fermentation. The strains in the composite Bifidobacterium preparation consist of Bifidobacterium animalis subsp. lactis strain BLa36, Bifidobacterium longum strain BL21, Bifidobacterium breve strain BBr60, Bifidobacterium adolescentis strain BAC30, and Bifidobacterium infantis strain Bl45. In the present application, the five specific types of different Bifidobacterium strains are compounded. There are potential interactions between the five strains, enabling the strains to cooperate with each other and produce synergistic effects in terms of enhancing the gastric juice tolerance of the strains and improving the overall survival rate of fermentation strains. When used in combination with a basic fermentation strain for yogurt fermentation, the composite Bifidobacterium preparation can significantly improve the acid tolerance of lactic acid bacteria in yogurt, thereby leading to a substantial increase in the number of live bacteria that enter the human intestinal tract and exert functions therein. Furthermore, the composite Bifidobacterium preparation can significantly promote intestinal peristalsis and gastric motility, ameliorate imbalances in intestinal flora, and promote intestinal health.

This disclosure belongs to the field of medical device and clinical monitoring technology. Specifically, it discloses a method and system for regulating enteral nutrition infusion based on real-time feedback of intragastric pressure. Specifically, it includes: dynamically adjusting the infusion rate to optimize the patient's individualized gastric motility response by real-time monitoring of the patient's intragastric pressure signal and infusion rate command signal, combined with waveform recognition, feature extraction, system identification, and predictive models. This disclosure achieves a technological leap from passive response to active regulation through deep identification and predictive utilization of intragastric pressure signals, improving the safety of enteral nutrition infusion; it realizes dynamic individualization and adaptive adjustment of the infusion strategy, improving the accuracy and effectiveness of nutritional support; and by introducing multi-objective collaborative optimization decision-making, it achieves optimal overall infusion control.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for improving gastrointestinal motility disorder and a preparation method thereof, and the traditional Chinese medicine composition is prepared from the following raw materials: fried malt, fried rice sprout, poria cocos, fructus amomi and liquorice. The traditional Chinese medicine composition disclosed by the invention can improve clinical symptoms such as postprandial fullness, early satiety, epigastric pain and epigastric discomfort caused by gastrointestinal motility disorder, epigastric burning feeling and epigastric spasmodic pain; insufficient gastric motility caused by gastrointestinal motility disorder is relieved, and nausea, vomiting, ozostomia, sour regurgitation or bitter regurgitation in the mouth are improved; the traditional Chinese medicine is used for treating weakness of spleen and stomach, and improving the symptoms of poor appetite, anorexia, fatigue, intolerance of cold, cold limbs and sweet excrement caused by stomach cold dull pain, stomach cold distention and fullness, warm and press liking.

The invention relates to the technical field of breathing masks, in particular to an intelligent anesthesia induction mask capable of monitoring gastric retention, the intelligent anesthesia induction mask comprises a mask body and an ultrasonic detection module, and the mask body is communicated with a breathing tube; a smell detection module used for detecting smell data in the oral cavity is communicated in the breathing tube, and the smell detection module is electrically connected with a controller; the controller is electrically connected with a myoelectricity electrode used for stimulating swallowing related muscles, and the controller is used for sending an ultrasonic verification instruction to the outside based on comparison of smell data and retention comparison data when the myoelectricity electrode is started; the controller is further used for acquiring an ultrasonic image at the current time based on the ultrasonic verification instruction, acquiring a real-time gastric motility parameter based on the ultrasonic image in unit time, and sending a gastric retention risk reminding instruction to the outside when the real-time gastric motility parameter is inconsistent with a set comparison gastric motility parameter; the residual volume of the stomach is dynamically evaluated through the ultrasonic sensor, and decision support is provided for anesthetists.

The invention belongs to the technical field of medical diagnosis equipment, and discloses a flexible spiral microstructure piezoresistive gastric motility detection catheter, which is a small-diameter flexible disposable catheter, is suitable for being placed through an oral-gastric path, and comprises a sensing section, a flexible transmission section and an in-vitro interface section which are connected in sequence, wherein the sensing section is located in the stomach and used for acquiring gastric motility signals, and the in-vitro interface section is arranged outside the body and connected with a signal acquisition device and can be integrally removed after detection is completed. According to the invention, through a node type structure amplification mechanism, the detection capability of weak gastric peristalsis pressure signals is improved; through the spiral microstructure and inner wall enhancement design, the conductive stability is realized under the conditions of small diameter and high flexibility, and the cable is suitable for long-time retention; the catheter is high in tolerance, continuous gastric motility data can be obtained in a natural physiological state, and a new technical means is provided for clinical function evaluation.

The invention relates to the technical field of food processing, and discloses a biscuit with the efficacy of promoting gastrointestinal motility and a preparation method of the biscuit. Components with the efficacy of coordinating intestines and stomach and regulating qi and guiding qi downward, such as amomum tsao-ko extract, inulin and metabiotics, are added into a formula of the biscuit; and a long-acting gastrointestinal tract conditioning effect is provided for people who are easy to flatulence and insufficient in gastric motility. The biscuit with the function of promoting gastrointestinal motility can avoid premature degradation of the metagen, the amomum tsao-ko extract and the MLCT in the stomach and the small intestine, effectively protect the activity of the metagen, ensure that enough metagen reaches the colon to be utilized by bifidobacterium, ensure that the MLCT and the amomum tsao-ko extract are released in the intestinal tract, effectively improve the absorption rate of active substances, and improve the immunity of the human body. The bioavailability of the biscuit is improved.

The present invention belongs to the technical field of modernization of traditional Chinese medicine, and in particular to a composition, application and product for preventing or treating chronic atrophic gastritis. The composition for preventing or treating chronic atrophic gastritis provided by the present invention is composed of isobarbin, ginsenoside Re, naringin, ginsenoside Rc and dioscorea lignin. The composition provided by the present invention can inhibit the PI3K / AKT pathway of inflammatory cells, activate the MAPK pathway of gastric mucosal epithelial cells, inhibit the expression of inflammatory factors such as IL-6 and TNF-α and promote GAST gastrin gene expression, thereby inhibiting inflammation, promoting gastrin secretion, enhancing gastric motility and promoting gastric mucosal epithelial cell repair, and achieving the effect of preventing or treating chronic atrophic gastritis. In addition, the components of the composition of the present invention are abundant in the medicinal and edible products of the Araliaceae family and the Rutaceae family, have low toxic and side effects, and show good application prospects in the preparation of drugs for preventing or treating chronic atrophic gastritis.

This invention discloses a traditional Chinese medicine composition for the prevention and / or treatment of gastric ulcers and / or their complications. By weight, the composition comprises: 2-6 parts of Atractylodes lancea, 2-6 parts of Poria cocos, 1-4 parts of Magnolia officinalis, 2-6 parts of Aucklandia lappa, 1-4 parts of Lindera strychnifolia, 1-4 parts of Cyperus rotundus, 1-4 parts of Alpinia officinarum, 1-4 parts of Amomum villosum, 1-4 parts of Coix lacryma-jobi, 1-4 parts of Citrus reticulata peel, 1-4 parts of Citrus medica, 1-4 parts of Crataegus pinnatifida, 1-4 parts of Massa fermentata, 1-4 parts of Hordeum vulgare, 1-4 parts of Gallus gallus domesticus gizzard lining, 1-4 parts of Bletilla striata, 2-6 parts of Paeonia lactiflora, 2-6 parts of Corydalis yanhusuo, 1-4 parts of Cinnamomum cassia, and 1-4 parts of Piper longum. The complications are selected from one or more of the following: pain, inflammation, and delayed gastric emptying. This traditional Chinese medicine composition is safe, effective, and has a simple and efficient preparation method with controllable quality. It exhibits significant anti-inflammatory, analgesic, and gastric motility-promoting effects, and can reduce the colonization of Helicobacter pylori in the stomach. It also has significant therapeutic effects on gastric ulcers induced by different factors (Helicobacter pylori infection, pyloric ligation, and nonsteroidal anti-inflammatory drugs).